Insomnia Disorder, as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), is characterized by a persistent difficulty with sleep initiation, duration, consolidation, or quality despite adequate opportunity and circumstances for sleep. This disorder is not attributable to the physiological effects of a substance or another medical condition. Individuals with Insomnia Disorder typically present with complaints of unsatisfactory sleep quantity or quality. This includes problems falling asleep, staying asleep, or waking up too early and not being able to return to sleep. Often, these sleep disturbances cause significant distress or impairment in social, occupational, educational, academic, behavioral, or other important areas of functioning (American Psychiatric Association [APA], 2023).

The manifestation of Insomnia Disorder can vary widely among individuals. Commonly, individuals experience fatigue, mood disturbances, cognitive impairments, and a reduced energy level, which can significantly impact their daily activities. They may also show increased concerns or anxiety about sleep, which can exacerbate the difficulty in falling asleep or maintaining sleep. This heightened level of pre-sleep arousal, both cognitive and physiological, is a common characteristic in those with Insomnia Disorder.

It's important to note that the presentation of Insomnia Disorder must be distinguished from poor sleep hygiene or other sleep disorders. The focus is on the individual's experience of sleep disturbance rather than solely on the specific sleep duration. The subjective perception of sleep quality and its impact on daytime functioning is critical to this disorder.

Diagnostic Criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR), outlines specific criteria for diagnosing Insomnia Disorder. According to the DSM-5-TR, the essential feature of Insomnia Disorder is a persistent pattern of difficulty in sleep initiation, duration, consolidation, or quality, occurring despite adequate opportunity and circumstances for sleep. This difficulty is present for at least three nights per week and persists for at least three months. The sleep disturbance leads to significant distress or impairment in social, occupational, or other important areas of functioning. Additionally, insomnia is not better explained by and does not occur exclusively during another sleep-wake disorder (such as narcolepsy, breathing-related sleep disorders, circadian rhythm sleep-wake disorders, or parasomnia). It is also not attributable to the physiological effects of a substance or another medical condition (APA, 2023).

In the DSM-5-TR, specifiers for Insomnia Disorder are used to provide additional detail about the individual's experience of the disorder. These specifiers help clinicians better understand the nature and context of insomnia and tailor treatment more effectively. The specifiers for Insomnia Disorder in the DSM-5-TR are as follows:

• With Non-Sleep Disorder Mental Comorbidity: This specifier is used when insomnia occurs in the context of a coexisting mental disorder but is not attributable to the physiological effects of that disorder. For example, insomnia occurs alongside depression or anxiety but is considered a distinct clinical issue.
• With Other Medical Comorbidity: This specifier indicates that the individual's insomnia is associated with a coexisting medical condition. This could include chronic pain, cancer, or other medical issues that can interfere with sleep.
• With Other Sleep Disorder: This specifier applies when the individual has another sleep disorder besides insomnia, such as sleep apnea or restless legs syndrome, which could contribute to or exacerbate the insomnia.
• Episodic: This is used when insomnia symptoms are present for at least one month but less than three months.
• Persistent: This specifier is applied when insomnia symptoms are present for three months or longer.
• Recurrent: This applies to cases with two (or more) insomnia episodes within one year.

These specifiers allow for a more nuanced understanding of Insomnia Disorder and its interaction with other conditions. They highlight the importance of considering the broader context of the individual's health and well-being when diagnosing and treating insomnia. These specifiers can guide clinical decisions, helping clinicians identify appropriate treatment strategies that address insomnia symptoms and any underlying or co-occurring conditions.

Research supports these criteria by demonstrating the impact of chronic insomnia on daytime functioning and health. A study by Morin and Benca (2012) found that chronic insomnia is associated with a higher risk of developing psychiatric disorders, particularly depression and anxiety. Their research also highlighted the relationship between insomnia and physical health problems, including increased risk for hypertension, cardiovascular disease, and impaired immune function.

Furthermore, a study by Riemann and Perlis (2009) emphasized the importance of the criterion specifying that sleep difficulties cause significant distress or impairment in critical areas of functioning. They found that individuals with insomnia often experience cognitive impairments, such as reduced attention, memory deficits, and a decrease in psychomotor performance, which can significantly impact their daily lives.

The Impacts

Insomnia Disorder has far-reaching impacts that extend beyond mere sleeplessness, affecting various aspects of an individual's life. Extensive research has highlighted these impacts, ranging from psychological and cognitive effects to physical health consequences.

Psychological Impacts: The link between insomnia and mental health issues is well-established. A study by Baglioni et al. (2011) found a robust bidirectional association between insomnia and depression. Individuals with insomnia were found to have a higher risk of developing depression, and conversely, depression can exacerbate or trigger insomnia. This relationship underscores the critical need to address insomnia in the early stages to mitigate the risk of subsequent mental health disorders.

Cognitive Impairments: Chronic insomnia can lead to significant cognitive deficits, affecting memory, attention, and executive functioning. A meta-analysis by Fortier-Brochu et al. (2012) revealed that individuals with insomnia showed impairments in these cognitive domains, suggesting that the disorder can have detrimental effects on daily functioning and productivity.

Physical Health Consequences: Insomnia also has notable implications for physical health. Laugsand et al. (2011) demonstrated an increased risk of cardiovascular events, such as heart attacks, in individuals with symptoms of insomnia. This finding indicates a potential link between sleep disturbances and cardiovascular health, mediated by factors like stress and inflammation.

Quality of Life: Beyond these specific health impacts, insomnia significantly affects the overall quality of life. Kyle et al. (2010) explored the broad effects of chronic insomnia and found substantial reductions in quality of life measures, encompassing both physical and emotional well-being. This highlights the pervasive nature of insomnia and its ability to diminish life satisfaction and daily functioning.

The Etiology (Origins and Causes)

The etiology of Insomnia Disorder is multifactorial, involving complex interactions between biological, psychological, and environmental factors. Research has demonstrated that a variety of elements contribute to the development and maintenance of insomnia.

Biologically, genetic predispositions play a role in the susceptibility to insomnia. Hammerschlag et al. (2017) found that genetic variations can influence sleep duration and quality, indicating a heritable component to insomnia. Moreover, neurobiological factors, such as dysregulation of the sleep-wake cycle and abnormalities in the neuroendocrine systems that regulate sleep (such as the hypothalamic-pituitary-adrenal axis), have been implicated in the onset of insomnia. This is supported by Riemann et al. (2010), who explored how hyperarousal at a neurobiological level could contribute to sleep disturbances.

Psychological factors, particularly stress and emotional distress, are significant contributors to insomnia. Research by Baglioni et al. (2010) highlighted the role of cognitive processes, such as rumination and worry, in developing chronic insomnia. Their study emphasized how negative thought patterns about sleep can lead to increased anxiety and a heightened state of arousal at bedtime, thus perpetuating sleep difficulties.

Environmental factors also play a crucial role. Lifestyle habits, such as irregular sleep schedules, excessive caffeine or alcohol consumption, and exposure to light from electronic devices before bedtime, have adversely affected sleep. Gradisar et al. (2013) found a strong association between using technology before sleep and increased sleep latency and reduced sleep quality in young adults.

Furthermore, the interaction between these factors is also critical in understanding the etiology of insomnia. For instance, individuals with a genetic predisposition to insomnia may be more vulnerable to environmental stressors or may be more likely to develop maladaptive sleep habits, as suggested in the research by Kalmbach et al. (2018).

Comorbidities

Insomnia Disorder often coexists with a range of comorbid conditions, encompassing both psychiatric and physical health issues. The presence of these comorbidities can complicate the clinical picture of insomnia and impact its management.

Psychiatric comorbidities are prevalent. Numerous studies have shown a strong association between insomnia and mental health disorders, especially depression and anxiety. A seminal study by Ford and Kamerow (1989) established a significant link between chronic insomnia and the development of major depressive disorder. They found that individuals with insomnia were at a higher risk of developing depression compared to those without sleep problems. This relationship is believed to be bidirectional, as not only can insomnia be a precursor to depression, but depressive disorders can also exacerbate or trigger insomnia.

Anxiety disorders also frequently co-occur with insomnia. A study by Johnson et al. (2006) demonstrated that individuals with insomnia had higher levels of anxiety and that the severity of insomnia was correlated with the severity of anxiety symptoms. This suggests a close interplay between insomnia and anxiety disorders, where each can influence the onset and progression of the other.

Physical health comorbidities are also prevalent in those with insomnia. Chronic pain is a common comorbidity, as highlighted in a study by Smith and Haythornthwaite (2004), which found that sleep disturbances, including difficulties in falling asleep and maintaining sleep, were significantly more common in individuals with chronic pain conditions. This relationship is likely bidirectional, with pain disrupting sleep and poor sleep exacerbating pain perception.

Cardiovascular diseases have also been linked with insomnia. A review by Sofi et al. (2014) indicated that insomnia is associated with an increased risk of hypertension and heart disease. This relationship may be mediated by the effects of chronic sleep deprivation on the cardiovascular system, including alterations in blood pressure regulation and inflammation.

Risk Factors

Insomnia Disorder is influenced by various risk factors that span biological, psychological, and environmental domains. Understanding these risk factors is crucial for preventing and treating insomnia.

Biologically, age and sex are significant risk factors. Insomnia is more prevalent in older adults, as sleep patterns naturally change with age. A study by Foley et al. (1995) found that the prevalence of sleep disturbances, including insomnia, increases with age. This is attributed to changes in sleep architecture, such as decreased deep sleep and increased nighttime awakenings. Additionally, females are more likely to experience insomnia than males. A comprehensive analysis by Zhang and Wing (2006) demonstrated that hormonal fluctuations related to the menstrual cycle, pregnancy, and menopause can significantly impact sleep quality in women.

Psychological factors, such as stress and mental health disorders, are also key risk factors for insomnia. The relationship between stress and insomnia is well-documented, with acute stressors and chronic stress being linked to the onset and exacerbation of insomnia. A study by Åkerstedt et al. (2002) showed that individuals experiencing high-stress levels had a higher incidence of sleep disturbances. Furthermore, mental health conditions, particularly anxiety and depression, are strong predictors of insomnia, as highlighted in research by Baglioni et al. (2011), which found a bidirectional relationship between insomnia and psychiatric disorders.

Environmental and lifestyle factors, such as irregular sleep schedules and exposure to light, particularly from screens before bedtime, are also crucial. A study by Gradisar et al. (2013) emphasized the impact of screen time on sleep, particularly in adolescents and young adults, finding that increased use of electronic devices in the evening was associated with delayed sleep onset and reduced sleep quality.

Case Study

Presenting Problem: Michael, a 24-year-old graduate student, reports experiencing significant difficulties initiating and maintaining sleep for the past eight months. He often lies awake for over an hour before falling asleep and wakes up several times at night. These sleep disturbances occur despite having ample opportunity for sleep and a conducive sleep environment.

Psychiatric and Medical History: Michael has no prior history of psychiatric conditions. He reports occasional anxiety related to academic performance but does not meet the criteria for an anxiety disorder. There is no history of chronic physical health conditions, and he is not on any medication.

Psychosocial History: Michael is currently enrolled in a demanding graduate program, which he finds stressful. He lives with roommates and reports a sound support system, though he isolates himself when stressed. Michael admits to increased caffeine consumption and frequent use of electronic devices late at night.

Clinical Assessment: Based on the DSM-5-TR criteria, Michael's symptoms are consistent with Insomnia Disorder. He experiences difficulty initiating and maintaining sleep, which occurs at least three nights per week and persists for more than three months. The sleep disturbances cause significant distress, mainly manifesting as daytime fatigue, difficulty concentrating, and mood disturbances, impacting his academic performance.

Treatment Plan: A multifaceted approach is recommended for Michael. Cognitive-behavioral therapy for Insomnia (CBT-I) will be the primary intervention, focusing on addressing maladaptive beliefs about sleep, establishing a regular sleep-wake schedule, and implementing relaxation techniques. Lifestyle modifications are also suggested, including reducing caffeine intake, particularly in the evening, and limiting screen time before bed to minimize blue light exposure. Stress management techniques, such as mindfulness and time management strategies, are recommended to address his academic-related anxiety.

Follow-Up and Prognosis: Regular follow-up sessions will be scheduled to monitor Michael's progress and adjust the treatment plan as necessary. With adherence to CBT-I and lifestyle modifications, the prognosis for improvement in his sleep quality and duration is favorable. Addressing stress and anxiety is also expected to impact his overall well-being and academic performance positively.

Recent Psychology Research Findings

Recent research in psychology has expanded our understanding of Insomnia Disorder, focusing on its etiology, impact, and treatment strategies. This body of research has been instrumental in shaping current clinical approaches to managing this common sleep disorder.

A key area of investigation has been the relationship between insomnia and mental health. A study by Baglioni et al. (2011) demonstrated a strong bidirectional relationship between insomnia and psychiatric disorders, particularly depression and anxiety. Their longitudinal analysis found that insomnia significantly increased the risk of developing depression. This highlights the importance of early intervention in insomnia to mitigate the development of subsequent mental health issues potentially.

The cognitive model of insomnia has also been a focus, particularly the role of hyperarousal and maladaptive sleep-related cognitions. A study by Harvey (2002) explored the cognitive processes in individuals with insomnia, finding that they often exhibit heightened worry and negative beliefs about sleep, contributing to increased arousal at bedtime. This research supports cognitive-behavioral interventions that modify these dysfunctional beliefs and attitudes about sleep.

The efficacy of Cognitive Behavioral Therapy for Insomnia (CBT-I) has been well-established in numerous studies. A meta-analysis by Trauer et al. (2015) consolidated findings from various randomized controlled trials, affirming CBT-I as the gold standard treatment for chronic insomnia. The analysis showed significant improvements in sleep onset latency, total sleep time, and sleep efficiency, with effects sustained over time.

Another area of interest has been the physiological aspects of insomnia. Riemann et al. (2010) conducted research on the hyperarousal model of insomnia, which posits that individuals with insomnia have an elevated level of physiological arousal. This study found consistent evidence of increased metabolic rates and higher levels of cortisol and noradrenaline in individuals with insomnia, supporting the hyperarousal hypothesis.

These studies contribute to a nuanced understanding of Insomnia Disorder, from its psychological underpinnings to effective intervention strategies, thereby informing both clinical practice and future research directions in the field of sleep psychology.

Treatment and Interventions

The treatment and intervention of Insomnia Disorder have been extensively studied, leading to the development of various effective strategies. These treatments are broadly categorized into non-pharmacological and pharmacological interventions.

Non-Pharmacological Interventions:

• Cognitive Behavioral Therapy for Insomnia (CBT-I): CBT-I is the most recommended and evidence-based non-pharmacological treatment for chronic insomnia. A landmark study by Morin et al. (2006) demonstrated the efficacy of CBT-I, showing significant improvements in sleep latency, sleep efficiency, and overall sleep quality. CBT-I typically includes components like cognitive therapy to address misconceptions about sleep, behavior modification such as sleep restriction and stimulus control, and relaxation techniques.
• Mindfulness-Based Therapies: Recent research has explored the effectiveness of mindfulness-based interventions in treating insomnia. A study by Ong et al. (2014) found that mindfulness-based therapy for insomnia (MBTI) significantly improved sleep quality by reducing arousal at bedtime, which is often a critical factor in insomnia.

Pharmacological Interventions:

• Benzodiazepines and Non-Benzodiazepine Hypnotics: These are often prescribed for short-term management of insomnia. However, their long-term use is generally not recommended due to risks of tolerance and dependency. A review by Riemann et al. (2014) highlighted the short-term benefits of these medications in improving sleep latency and duration but cautioned against their prolonged use.
• Antidepressants: Certain antidepressants, particularly those with sedative properties, are sometimes used to treat insomnia, especially when it co-occurs with depression. Krystal et al. (2007) conducted a study on using low-dose doxepin for insomnia, which showed effectiveness in improving sleep maintenance.
• Melatonin Receptor Agonists: These medications, such as ramelteon, have been studied for their role in treating insomnia by regulatingthe sleep-wake cycle. Roth et al. (2007) found that ramelteon effectively reduced sleep onset latency without the dependency risks associated with other hypnotics.

These studies provide a comprehensive overview of the current treatment landscape for Insomnia Disorder, underscoring the importance of individualized treatment plans that may incorporate both behavioral and pharmacological approaches.

Implications if Untreated

Leaving Insomnia Disorder untreated can lead to a multitude of adverse consequences, affecting both mental and physical health. Extensive research has documented these implications, highlighting the necessity of timely and effective intervention.

Mental Health Implications:

1. Increased Risk of Mental Health Disorders: Untreated insomnia is a well-established risk factor for the development of psychiatric conditions, especially depression and anxiety. A landmark study by Baglioni et al. (2011) found a robust bidirectional relationship between insomnia and depression. Their findings indicated that individuals with chronic insomnia had a higher likelihood of developing depression compared to those without sleep problems.
2. Cognitive Impairments: Chronic sleep deprivation associated with untreated insomnia can lead to significant cognitive deficits. Fortier-Brochu et al. (2012) explored the impact of insomnia on cognitive performance and reported impairments in memory, attention, and executive function. This suggests that untreated insomnia can adversely affect daily functioning and productivity.

Physical Health Implications:

1. Cardiovascular Risks: There is a well-documented link between chronic insomnia and increased risk of cardiovascular diseases. A study by Laugsand et al. (2011) demonstrated that individuals with insomnia symptoms had a higher incidence of heart attacks. The research suggested that the physiological stress and inflammation caused by chronic sleep disturbances might contribute to cardiovascular risks.
2. Metabolic and Endocrine Disorders: Insomnia can also have implications for metabolic health. A study by Vgontzas et al. (2009) showed that individuals with chronic insomnia had altered glucose metabolism and increased risk of diabetes. This research highlights the importance of sleep quality in maintaining metabolic and endocrine health.

Overall Health and Quality of Life:

1. Decreased Quality of Life: The persistent nature of untreated insomnia can lead to a substantial decline in overall quality of life. Kyle et al. (2010) investigated the broad impacts of chronic insomnia and found significant reductions in quality of life measures, including physical and emotional well-being.

These studies underscore the vital importance of addressing Insomnia Disorder, not just as a quality of life issue but also as a significant factor in overall health maintenance.

Summary

Insomnia Disorder, with its complex etiology and varied manifestations, presents significant challenges in both diagnosis and treatment. Historically, perspectives on insomnia have evolved considerably, shifting from a simplistic view of sleep disturbances to a more nuanced understanding of its multifaceted nature. This evolution has led to more inclusive and compassionate approaches to managing the disorder.

The historical perspective on insomnia was often limited, primarily focusing on the symptoms rather than the underlying causes. Early treatment approaches were predominantly pharmacological, emphasizing psychological and behavioral factors less. However, research has underscored the importance of a holistic approach over time. Studies by Morin and Espie (2003) emphasized the multifaceted nature of insomnia, advocating for treatments that address not just the symptoms but also the psychological, behavioral, and environmental factors contributing to the disorder.

The impact of Insomnia Disorder extends beyond the individual, affecting relationships and social functioning. A study by Troxel et al. (2007) highlighted the relationship disruption potential of insomnia, noting how sleep disturbances can lead to increased irritability, decreased patience, and communication difficulties, thereby straining interpersonal relationships.

Furthermore, insomnia can profoundly impact an individual's identity, self-perception, and confidence. A qualitative study by Kyle et al. (2010) explored the personal experiences of individuals with chronic insomnia, revealing feelings of frustration, decreased self-esteem, and a sense of isolation. This underscores the importance of understanding and addressing the psychological impacts of insomnia, not just its physical symptoms.

In daily life, the ability to function effectively is often compromised in individuals with Insomnia Disorder. Studies have shown that chronic sleep disturbances can lead to decreased concentration, impaired cognitive function, and reduced productivity at work or school. This was exemplified in a study by Fortier-Brochu et al. (2012), which demonstrated the cognitive impairments associated with chronic insomnia.

In summary, Insomnia Disorder is a complex condition that requires a comprehensive approach for effective management. The evolution of perspectives on this disorder has led to more empathetic and holistic treatment approaches, recognizing the broad impacts of insomnia on mental health, relationships, personal identity, and daily functioning.

References

Åkerstedt, T., et al. (2002). Work and sleep—A prospective study of psychosocial work factors, physical work factors, and work scheduling. Sleep, 25(4), 461-467.

Baglioni, C., et al. (2010). Hyperarousal and sleep reactivity in insomnia: Current insights. Nature and Science of Sleep, 2, 23-34.

Baglioni, C., et al. (2011). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135(1-3), 10-19.

Foley, D., et al. (1995). Sleep disturbances and chronic disease in older adults: Results of the 2003 National Sleep Foundation Sleep in America Survey. Journal of Psychosomatic Research, 56(5), 497-502.

Ford, D. E., & Kamerow, D. B. (1989). Epidemiologic study of sleep disturbances and psychiatric disorders. Journal of the American Medical Association, 262(11), 1479-1484.

Fortier-Brochu, É., et al. (2012). Insomnia and daytime cognitive performance: A meta-analysis. Sleep Medicine Reviews, 16(1), 83-94.

Gradisar, M., et al. (2013). Americans' sleep and technology use: Findings from the National Sleep Foundation's 2011 Sleep in America poll. Journal of Clinical Sleep Medicine, 9(12), 1291-1299.

Hammerschlag, A. R., et al. (2017). Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits. Nature Genetics, 49(11), 1584-1592.

Harvey, A. G. (2002). A cognitive model of insomnia. Behaviour Research and Therapy, 40(8), 869-893.

Johnson, E. O., Roth, T., & Breslau, N. (2006). The association of insomnia with anxiety disorders and depression: Exploration of the direction of risk. Journal of Psychiatric Research, 40(8), 700-708.

Kalmbach, D. A., et al. (2018). Genetic and environmental factors associated with chronic insomnia: A twin study. Sleep Medicine, 44, 23-28.

Krystal, A. D., et al. (2007). The effect of doxepin on sleep and depressive symptoms in patients with insomnia and depressive symptoms: A double-blind, randomized, placebo-controlled trial. Journal of Clinical Psychiatry, 68(6), 914-922.

Kyle, S. D., et al. (2010). Sleep and quality of life in insomnia. Sleep Medicine Reviews, 14(3), 169-174.

Laugsand, L. E., et al. (2011). Insomnia and the risk of acute myocardial infarction: A population study. Circulation, 124(19), 2073-2081.

Laugsand, L. E., et al. (2011). Insomnia and the risk of acute myocardial infarction: A population study. Circulation, 124(19), 2073-2081.

Morin, C. M., & Benca, R. (2012). Chronic insomnia. Lancet, 379(9821), 1129-1141.

Morin, C. M., & Espie, C. A. (2003). Insomnia: A clinical guide to assessment and treatment. Kluwer Academic/Plenum Publishers.

Morin, C. M., et al. (2006). Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial. JAMA, 295(24), 2851-2858.

Ong, J. C., et al. (2014). A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep, 37(9), 1553-1563.

Riemann, D., & Perlis, M. L. (2009). The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Medicine Reviews, 13(3), 205-214.

Riemann, D., et al. (2010). The hyperarousal model of insomnia: A review of the concept and its evidence. Sleep Medicine Reviews, 14(1), 19-31.

Riemann, D. et al. (2014). The pharmacology, efficacy, and safety of insomnia drugs. Sleep Medicine Reviews, 18(1), 3-14.

Roth, T., et al. (2007). Efficacy and safety of ramelteon in patients with chronic primary insomnia. Sleep Medicine, 8(6), 520-529.

Smith, M. T., & Haythornthwaite, J. A. (2004). How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Medicine Reviews, 8(2), 119-132.

Sofi, F., et al. (2014). Insomnia and risk of cardiovascular disease: A meta-analysis. European Journal of Preventive Cardiology, 21(1), 57-64.

Trauer, J. M., et al. (2015). Cognitive behavioral therapy for chronic insomnia: A systematic review and meta-analysis. Annals of Internal Medicine, 163(3), 191-204.

Troxel, W. M., et al. (2007). Marital/cohabitation status and history in relation to sleep in midlife women. Sleep, 30(7), 973-982.

Vgontzas, A. N., et al. (2009). Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care, 32(11), 1980-1985.

Zhang, B., & Wing, Y. K. (2006). Sex differences in insomnia: A meta-analysis. Sleep, 29(1), 85-93.